Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

February’s top stories: 23andMe’s genetic carrier test, Cerner-Siemens $1.3bn deal

US Food and Drug Administration (FDA) granted approval for marketing 23andMe's Bloom Syndrome carrier test, a direct-to-consumer (DTC) genetic test to determine whether a healthy person has a variant in a gene that could lead to their offspring inheriting the disorder.

Go Top